TLR7-Mediated Lupus Nephritis Is Independent of Type I IFN Signaling

Systemic lupus erythematosus is an autoimmune disease characterized by increased type I IFNs, autoantibodies, and inflammatory-mediated multiorgan damage. TLR7 activation is an important contributor to systemic lupus erythematosus pathogenesis, but the mechanisms by which type I IFNs participate in TLR7-driven pathologic conditions remain uncertain. In this study, we examined the requirement for type I IFNs in TLR7-stimulated lupus nephritis. Lupus-prone NZM2328, INZM (which lack a functional type I IFN receptor), and NZM2328 IL-1β−/− mice were treated at 10 wk of age on the right ear with R848 (TLR7 agonist) or control (DMSO). Autoantibody production and proteinuria were assessed throughout treatment. Multiorgan inflammation was assessed at the time of decline in health. Renal infiltrates and mRNA expression were also examined after 14 d of treatment. Both NZM2328 and INZM mice exhibited a decline in survival after 3–4 wk of R848 but not vehicle treatment. Development of splenomegaly and liver inflammation were dependent on type I IFN. Interestingly, autoantibody production, early renal infiltration of dendritic cells, upregulation of IL-1β, and lupus nephritis occurred independent of type I IFN signaling. Development of TLR7-driven lupus nephritis was not abolished by the deletion of IL-1β. Thus, although IFN-α is sufficient to induce nephritis acceleration, our data emphasize a critical role for IFN-independent signaling in TLR7-mediated lupus nephritis. Further, despite upregulation of IL-1β after TLR7 stimulation, deletion of IL-1β is not sufficient to reduce lupus nephritis development in this model.

[1]  S. Manzi,et al.  Epidemiology of Systemic Lupus Erythematosus , 2019, Lupus - New Advances and Challenges.

[2]  B. Beutler,et al.  Induction of Systemic Autoimmunity by a Xenobiotic Requires Endosomal TLR Trafficking and Signaling from the Late Endosome and Endolysosome but Not Type I IFN , 2017, The Journal of Immunology.

[3]  H. Hsu,et al.  Cutting Edge: Endogenous IFN-β Regulates Survival and Development of Transitional B Cells , 2017, The Journal of Immunology.

[4]  J. Ochando,et al.  Follicular Dendritic Cell Activation by TLR Ligands Promotes Autoreactive B Cell Responses , 2017, Immunity.

[5]  P. Cohen,et al.  Suppression of IRAK1 or IRAK4 Catalytic Activity, but Not Type 1 IFN Signaling, Prevents Lupus Nephritis in Mice Expressing a Ubiquitin Binding–Defective Mutant of ABIN1 , 2016, The Journal of Immunology.

[6]  Ranjan Gupta,et al.  Longitudinal assessment of monocyte chemoattractant protein-1 in lupus nephritis as a biomarker of disease activity , 2016, Clinical Rheumatology.

[7]  H. Anders,et al.  Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis. , 2016, Clinical immunology.

[8]  X. Liao,et al.  Chemokines and Chemokine Receptors in the Development of Lupus Nephritis , 2016, Mediators of inflammation.

[9]  Y. H. Lee,et al.  Urinary MCP-1 as a biomarker for lupus nephritis: a meta-analysis , 2016, Zeitschrift für Rheumatologie.

[10]  M. Ward,et al.  Risk of End‐Stage Renal Disease in Patients With Lupus Nephritis, 1971–2015: A Systematic Review and Bayesian Meta‐Analysis , 2016, Arthritis & rheumatology.

[11]  Giljun Park,et al.  Interleukin 6 Accelerates Mortality by Promoting the Progression of the Systemic Lupus Erythematosus-Like Disease of BXSB.Yaa Mice , 2016, PloS one.

[12]  J. Hodgin,et al.  Epidermal injury promotes nephritis flare in lupus-prone mice. , 2015, Journal of autoimmunity.

[13]  B. Ni,et al.  A20 overexpression alleviates pristine-induced lupus nephritis by inhibiting the NF-κB and NLRP3 inflammasome activation in macrophages of mice. , 2015, International journal of clinical and experimental medicine.

[14]  J. Kearney,et al.  B cell autophagy mediates TLR7-dependent autoimmunity and inflammation , 2015, Autophagy.

[15]  D. Gladman,et al.  Interferon-α induces altered transitional B cell signaling and function in Systemic Lupus Erythematosus. , 2015, Journal of autoimmunity.

[16]  R. Kleemann,et al.  Establishment of a General NAFLD Scoring System for Rodent Models and Comparison to Human Liver Pathology , 2014, PloS one.

[17]  A. Davidson,et al.  Interferon alpha on NZM2328.Lc1R27: enhancing autoimmunity and immune complex-mediated glomerulonephritis without end stage renal failure. , 2014, Clinical immunology.

[18]  M. Kaplan,et al.  The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis? , 2014, Current opinion in rheumatology.

[19]  M. Crow.  Type I Interferon in the Pathogenesis of Lupus , 2014, The Journal of Immunology.

[20]  A. Davidson,et al.  Structure and Function of Renal Macrophages and Dendritic Cells From Lupus‐Prone Mice , 2014, Arthritis & rheumatology.

[21]  S. Sano,et al.  Epicutaneous Application of Toll‐like Receptor 7 Agonists Leads to Systemic Autoimmunity in Wild‐Type Mice: A New Model of Systemic Lupus Erythematosus , 2014, Arthritis & rheumatology.

[22]  Haoyang Zhuang,et al.  Toll‐like Receptor 7–Stimulated Tumor Necrosis Factor α Causes Bone Marrow Damage in Systemic Lupus Erythematosus , 2014, Arthritis & rheumatology.

[23]  J. Hodgin,et al.  An Essential Role of Caspase 1 in the Induction of Murine Lupus and Its Associated Vascular Damage , 2014, Arthritis & rheumatology.

[24]  V. Trouplin,et al.  Bone marrow-derived macrophage production. , 2013, Journal of visualized experiments : JoVE.

[25]  T. Imanishi‐Kari,et al.  Overexpression of TLR7 promotes cell-intrinsic expansion and autoantibody production by transitional T1 B cells , 2013, The Journal of experimental medicine.

[26]  R. K. Oliver,et al.  ABIN1 dysfunction as a genetic basis for lupus nephritis. , 2013, Journal of the American Society of Nephrology : JASN.

[27]  C. Alpers,et al.  Increased Ribonuclease Expression Reduces Inflammation and Prolongs Survival in TLR7 Transgenic Mice , 2013, The Journal of Immunology.

[28]  M. Shlomchik,et al.  Exacerbated Autoimmunity in the Absence of TLR9 in MRL.Faslpr Mice Depends on Ifnar1 , 2013, The Journal of Immunology.

[29]  M. Debatis,et al.  Activation of Autoreactive B Cells by Endogenous TLR7 and TLR3 RNA Ligands* , 2012, The Journal of Biological Chemistry.

[30]  D. Ye,et al.  The TLR7 7926A>G polymorphism is associated with susceptibility to systemic lupus erythematosus. , 2012, Molecular medicine reports.

[31]  Catalina Herrera-Díaz,et al.  Lupus Nephritis: An Overview of Recent Findings , 2012, Autoimmune diseases.

[32]  A. Farris,et al.  Toll-like Receptors in Systemic Lupus Erythematosus: Potential Targets for Therapeutic Intervention , 2012, Current Allergy and Asthma Reports.

[33]  P. Cohen,et al.  Polyubiquitin binding to ABIN1 is required to prevent autoimmunity , 2011, The Journal of experimental medicine.

[34]  A. Farris,et al.  Targeting Toll-Like Receptors for Treatment of SLE , 2010, Mediators of inflammation.

[35]  R. Cantor,et al.  Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus , 2010, Proceedings of the National Academy of Sciences.

[36]  J. Connolly,et al.  Type I Interferons Produced by Resident Renal Cells May Promote End-Organ Disease in Autoantibody-Mediated Glomerulonephritis1 , 2009, The Journal of Immunology.

[37]  C. Putterman,et al.  Deficiency of Type I IFN Receptor in Lupus-Prone New Zealand Mixed 2328 Mice Decreases Dendritic Cell Numbers and Activation and Protects from Disease1 , 2009, The Journal of Immunology.

[38]  H. Bagavant,et al.  Pathogenesis of kidney disease in systemic lupus erythematosus , 2009, Current opinion in rheumatology.

[39]  S. Zheng,et al.  Accelerated Pathological and Clinical Nephritis in Systemic Lupus Erythematosus-Prone New Zealand Mixed 2328 Mice Doubly Deficient in TNF Receptor 1 and TNF Receptor 2 via a Th17-Associated Pathway1 , 2009, The Journal of Immunology.

[40]  S. Akira,et al.  TLR7-dependent and FcγR-independent production of type I interferon in experimental mouse lupus , 2008, The Journal of experimental medicine.

[41]  J. Ward,et al.  Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. , 2007, Immunity.

[42]  Kindra M Kelly-Scumpia,et al.  Deficiency of the type I interferon receptor protects mice from experimental lupus. , 2007, Arthritis and rheumatism.

[43]  Minoru Satoh,et al.  Pivotal Role of Stat4 and Stat6 in the Pathogenesis of the Lupus-Like Disease in the New Zealand Mixed 2328 Mice 1 , 2003, The Journal of Immunology.

[44]  D. Lawrence,et al.  New Zealand mixed mice: a genetic systemic lupus erythematosus model for assessing environmental effects. , 1999, Environmental health perspectives.

[45]  A. Steinberg,et al.  Effects of UV radiation on autoimmune strains of mice: increased mortality and accelerated autoimmunity in BXSB male mice. , 1985, The Journal of investigative dermatology.

[46]  J. Roths,et al.  A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. , 1979, Arthritis and rheumatism.

[47]  H. Anders,et al.  Reprint of "Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis". , 2017, Clinical immunology.

[48]  M. Madaio,et al.  Interferon-α accelerates murine systemic lupus erythematosus in a T cell-dependent manner. , 2011, Arthritis and rheumatism.